Search

Your search keyword '"Bourdin, Arnaud"' showing total 1,165 results

Search Constraints

Start Over You searched for: Author "Bourdin, Arnaud" Remove constraint Author: "Bourdin, Arnaud"
1,165 results on '"Bourdin, Arnaud"'

Search Results

51. Efficacy and Safety of Benralizumab Compared with Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis in Patients Receiving Standard of Care Therapy: Phase 3 MANDARA Study

52. CT Imaging Assessment of Response to Treatment in Allergic Bronchopulmonary Aspergillosis in Adults With Bronchial Asthma

53. Defining a Severe Asthma Super-Responder: Findings from a Delphi Process

56. Prospective Multicenter Validation of the Detection of ALK Rearrangements of Circulating Tumor Cells for Noninvasive Longitudinal Management of Patients With Advanced NSCLC

57. Potential Severe Asthma Hidden in UK Primary Care

59. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

60. Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial

62. Healthcare Resource Utilization Associated with Intermittent Oral Corticosteroid Prescribing Patterns in Asthma.

63. Liver disease in germline mutations of telomere-related genes: Prevalence, clinical, radiological, pathological features, outcome, and risk factors.

64. Prevalence of anti-neutrophil cytoplasmic antibody-associated vasculitis in the south of France, using the capture-recapture method.

65. Similarities and differences of interstitial lung disease associated with pathogenic variants in SFTPC and ABCA3 in adults.

66. Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study

67. International Severe Asthma Registry: Mission Statement

68. Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma

69. Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma

70. Liver disease in germline mutations of telomere-related genes: Prevalence, clinical, radiological, pathological features, outcome, and risk factors

73. Adult Severe Asthma Registries: A Global and Growing Inventory

78. Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

80. Outcomes and risk assessment in pulmonary veno-occlusive disease.

81. Infections in autoimmune pulmonary alveolar proteinosis: a large retrospective cohort.

82. Infections in autoimmune pulmonary alveolar proteinosis: a large retrospective cohort

86. Phenotypic characterization of interstitial lung disease associated with mutations in SFTPC and ABCA3 in adults

87. High-dose aspirin in severe uncontrolled asthma associated with chronic rhinosinusitis with nasal polyps (CRwNP) : the ASTHMIRINE trial

89. Blunted vascular response to pulmonary rehabilitation in COPD patients and impaired exercise-induced mobilization of endothelial-colony forming cells

90. Lower respiratory tract involvement in recurrent respiratory papillomatosis in a multicentric cohort study

95. The Transcriptome Landscape of the In Vitro Human Airway Epithelium Response to SARS-CoV-2

Catalog

Books, media, physical & digital resources